Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,755 | -20,525 | -11,629 | -32,703 | -22,386 |
| Depreciation Amortization | -195 | 144 | -109 | -135 | -23 |
| Accounts receivable | -955 | -301 | 18 | 1,432 | 74 |
| Accounts payable and accrued liabilities | 985 | 661 | -54 | -335 | 287 |
| Other Working Capital | 467 | -556 | -1,183 | 1,939 | 715 |
| Other Operating Activity | 3,203 | 1,594 | 1,148 | 2,958 | 2,664 |
| Operating Cash Flow | $-28,250 | $-18,983 | $-11,809 | $-26,844 | $-18,669 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 21,310 | 10,274 | -2,783 | -29,462 | -38,604 |
| PPE Investments | -84 | -69 | -37 | -445 | -394 |
| Investing Cash Flow | $21,226 | $10,205 | $-2,820 | $-29,907 | $-38,998 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 621 | 525 | 138 | 44,953 | 44,950 |
| Common Stock Repurchased | -13 | N/A | -4 | N/A | -82 |
| Other Financing Activity | -1,333 | -346 | 84 | -3,037 | -2,942 |
| Financing Cash Flow | $-725 | $179 | $218 | $41,916 | $41,926 |
| Beginning Cash Position | 32,606 | 32,606 | 32,606 | 47,441 | 47,441 |
| End Cash Position | 24,857 | 24,007 | 18,195 | 32,606 | 31,700 |
| Net Cash Flow | $-7,749 | $-8,599 | $-14,411 | $-14,835 | $-15,741 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,250 | -18,983 | -11,809 | -26,844 | -18,669 |
| Capital Expenditure | -84 | -69 | -37 | -445 | -394 |
| Free Cash Flow | -28,334 | -19,052 | -11,846 | -27,289 | -19,063 |